Impaktované publikace
[1]
Belickova, M.; Vesela, J.; Jonasova, A.; Pejsova, B.; Votavova, H.; Dostalova Merkerova, M.; Zemanova, Z.; Brezinova, J.; Mikulenkova, D.; Lauermannova, M.; Valka, J.; Michalova, K.; Neuwirtova, R.; Cermak, J.
TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes
[rok vydání 2016, impact factor 5.168 ]
[2]
Belickova, M.; Dostalova Merkerova, M.; Votavova, H.; Valka, J.; Vesela, J.; Pejsova, B.; Hajkova, H.; Klema, J.; Cermak, J.; Jonasova, A.
Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms
[rok vydání 2016, impact factor 1.610 ]